Publicacións en colaboración con investigadores/as de Universidad Católica de Valencia San Vicente Mártir (11)

2023

  1. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT)

    British Journal of Haematology, Vol. 203, Núm. 5, pp. 860-871

  2. The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study

    Cancers, Vol. 15, Núm. 11

2022

  1. Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles

    Frontiers in Medicine, Vol. 9

2021

  1. Complement component C1q as a potential diagnostic tool for myalgic encephalomyelitis/chronic fatigue syndrome subtyping

    Journal of Clinical Medicine, Vol. 10, Núm. 18

  2. Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial

    European Journal of Cancer, Vol. 148, pp. 382-394

2020

  1. Activation of transposable elements in immune cells of fibromyalgia patients

    International Journal of Molecular Sciences, Vol. 21, Núm. 4

  2. Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Scientific Reports, Vol. 10, Núm. 1

  3. Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 10, pp. 5865-5877

2019

  1. Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation

    Clinical Therapeutics, Vol. 41, Núm. 4, pp. 675-698

  2. Impact of polypharmacy on candidate biomarker mirnomes for the diagnosis of fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: Striking back on treatments

    Pharmaceutics, Vol. 11, Núm. 3

2010

  1. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

    Transfusion and Apheresis Science, Vol. 43, Núm. 3, pp. 299-303